Narcissus and Daffodil

206 J. Bastida and F. Viladomat
Han, S.Y., Sweeney, J.E., Bachman, E.S., Schweiger, E.J., Forloni, G., Coyle, J.T., Davis,
B.M. and Joullié, M.M. (1992) Chemical and pharmacological characterization of galanthamine,
an acetylcholinesterase inhibitor, and its derivatives. A potential application in
Alzheimer’s disease? European Journal of Medicinal Chemistry, 27, 673–687.
Hanson, K.R. (1966) Applications of the sequence rule. I. Naming the paired ligands g,g at
a tetrahedral atom Xggij. II. Naming the two faces of a trigonal atom Yghi. Journal of the
American Chemical Society, 88, 2731–2742.
Harken, R.D., Christensen, C.P. and Wildman, W.C. (1976) Interconversions in the pluviine-lycorenine
series. Journal of Organic Chemistry, 41, 2450–2454.
Harvey, A.L. (1995) The pharmacology of galanthamine and its analogs. Pharmacology and
Therapeutics, 68, 113–128.
Haugwitz, R.D., Jeffs, P.W. and Wenkert, E. (1965) Proton magnetic resonance spectral
studies of some Amaryllidaceae alkaloids of the 5,10b-ethanophenanthridine series and
of criwelline and tazettine. Journal of the Chemical Society (B), 2001–2009.
Hauth, H. and Stauffacher, D. (1964) Die alkaloide von Crinum macrantherum Engl. Helvetica
Chimica Acta, 47, 185–194.
Hawksworth, W.A., Jeffs, P.W., Tidd, B.K. and Toube, T.P. (1965) The alkaloids of the
Amaryllidaceae. Part XII. The aromatic oxygenation patterns and stereochemistry of
some trioxyaryl alkaloids of the hemiacetal and lactone series. Journal of the Chemical
Society, 1991–2001.
Hermann, A.M. and Mucke, P.D. (1997a) Principles of therapeutics of galanthamine. Drugs
of Today, 33, 251–257.
Hermann, A.M. and Mucke, P.D. (1997b) Preclinical studies with galanthamine. Drugs of
Today, 33, 259–264.
Hoshino, O., Ishizaki, M., Kamei, K., Taguchi, M., Nagao, T., Iwaoka, K., Sawaki, S.,
Umezawa, B. and Iitaka, Y. (1996) Potential intermediate, (+/–)-di-O-acetyl-3αphenylselanyl-3,3a-dihydro-B-nor-6,7a-secolycorin-5-one
for synthesis of the Amaryllidaceae
alkaloid lycorine: Formal and total syntheses of (+/–)-lycorine. Journal of the
Chemical Society Perkin Transactions I, 571–580.
Hua, D.H., Saha, S. and Takemoto, D.J. (1997) Anticancer activities of 2,5,8,9-substituted
6-oxo-1,2,3,4,5,6-hexahydrophenanthridines on multi-drug-resistant phenotype cells.
Anticancer Research, 17, 2435–2442.
Hung, S.H., Chen, Z.X. and Li, C.F. (1962) Studies on the alkaloids of Amaryllidaceae.
II. A new method for the isolation of pseudolycorine and search of plants rich in lycorine.
Yao Hsueh Hsueh Pao, 9, 719–724 (in Chinese).
Hung, S.H., Ma, G.E. and Chu, M. (1966) Alkaloids of Amaryllidaceae. VII. Suisenine.
Yao Hsueh Hsueh Pao, 13, 499–502 (in Chinese).
Hung, S.H., Ma, G.E. and Sung, S.Q. (1981) Studies on the alkaloids of Amaryllidaceae.
V. The alkaloids of Narcissus papyraceus Ker-Gawl and the structure of a new alkaloid,
papyramine. Acta Chimica Sinica, 39, 529–539 (in Chinese).
Ibuka, T., Irie, H., Kato, A.,Uyeo, S., Kotera, K. and Nakagawa, Y. (1966) Mass spectrometry
of some Amaryllidaceae alkaloids. Tetrahedron Letters, 4745–4748.
Ide, S., Sener, B., Temizer, H. and Könükol, S. (1996) The crystal and molecular structure of
two drug compounds: Tazettine and corydaldine. Crystal Research and Technology, 31, 617–624.
Ieven, M., Van den Berghe, D.A., Mertens, F., Vlietinck, A. and Lammens, E. (1979)
Screening of higher plants for biological activities I. Antimicrobial activity. Planta Medica,
36, 311–321.
Ieven, M., Vlietinck, A., Van den Berghe, D.A., Totte, J., Dommisse, R., Esmans, E. and
Alderweireldt, F. (1982) Plant antiviral agents III. Isolation of alkaloids from Clivia
miniata Regel (Amaryllidaceae). Journal of Natural Products, 45, 564–573.
Ieven, M., Van den Berghe, D.A. and Vlietinck, A. (1983) Plant antiviral agents. Planta
Medica, 49, 109–114.